Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Recruiting · NCT05918302 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, Thymus Neoplasms, lung neuroendocrine neoplasm, lymphatic system disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-05-12 | NCT05918302 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grupo Espanol de Tumores Neuroendocrinos | 4 |
| Lumara Bio Oncologics GmbH | 3 |
| MFAR | 9 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.